Search results
New COVID variants called 'FLiRT' are spreading in the U.S. What are the symptoms?
TODAY via Yahoo News· 4 hours agoThe new "FLiRT" COVID-19 variants, including KP.2, are spreading in the United States. Will there be...
‘Frances Oldham Kelsey, the FDA, and the Battle Against Thalidomide’ Review: The Noble Bureaucrat
The Wall Street Journal· 10 hours agoShe chose the Food and Drug Administration, she later said, because the FDA offered to pay her...
Should You Rinse Salmon Before Cooking? Here’s What the Experts Say
Simply Recipes via Yahoo News· 7 days agoThey do this to get rid of things like sand and dirt,” says Qinchun Rao, Ph.D., professor of food ...
Judge denies United Therapeutics' attempt to block Liquidia from expanding PAH drug - Triangle...
The Business Journals· 14 hours agoLiquidia's initial NDA, which it filed with the U.S. Food and Drug Administration in 2020, was for...
Liquidia Stock Surges After Winning Patent Battle Vs. United Therapeutics
Investor's Business Daily· 1 day agoThe news is a boon for Liquidia, which gained tentative Food and Drug Administration approval for...
FDA expands age range for BrainsWay Deep TMS treatment By Investing.com
Investing.com· 1 day agoColleen A. Hanlon, Ph.D., Vice President of Medical Affairs at BrainsWay, stated...
NIH scientists develop AI tool to predict how cancer patients will respond to immunotherapy
KSAN - KLST San Angelo· 1 day agoWhat: In a proof-of-concept study, researchers at the National Institutes of Health (NIH) have developed an artificial intelligence (AI) tool that uses routine clinical data, such as that from ...
Gel-based male birth control is safe and effective, scientists report
Salon via Yahoo News· 1 day agoPatients applied 5 milliliters of the drug combo between their shoulder blades every day for a...
BrainsWay Receives Expanded FDA Labeling to Treat Late Life Depression - BrainsWay (NASDAQ:BWAY)
Benzinga· 2 days ago(NASDAQ & TASE: BWAY) ("BrainsWay" or the "Company"), a global leader in advanced noninvasive neurostimulation treatments for mental health disorders, today announced that the US Food ...
...from Pivotal Phase 2 TRUST-I Study of Taletrectinib(ROS1 Inhibitor) are Published in the JCO and...
ThePress.net· 3 days agoInnovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the ...